Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chart: FDA's ANDA Approvals

Executive Summary

FDA's ANDA Approvals



FDA's ANDA Approvals

Applicant

Active Ingredients

Number

Date Approved

Ranbaxy

Hydrochlorothiazide/quinapril HCl, 12.5 mg; EQ 10 mg base, 12.5 mg; EQ 20 mg base and 25 mg; EQ 20 mg base tabs.

78-211

3/4/2009

Austarpharma

Sertraline HCl, EQ 25 mg base, EQ 50 mg base and EQ 100 mg base tabs.

78-677

3/4/2009

Sandoz

Methylprednisolone acetate, 40 mg/mL 80 mg/mL inj.

40-794

3/5/2009

West Ward

Glycopyrrolate, 1 mg and 2 mg tabs.

40-836

3/5/2009

Zydus

Divalproex sodium, EQ 125 mg, EQ 250 mg and EQ 500 mg valproic acid delayed-release tabs.

44-100

3/5/2009

Upsher Smith

Propranolol HCl, 60 mg, 80 mg, 120 mg and 160 mg extended-release caps.

78-311

3/6/2009

Synerx

Malathion, 0.5% topical lotion

78-743

3/6/2009

Ranbaxy

Ramipril, 5 mg and 10 mg caps.

78-849

3/6/2009

Avanthi

Indomethacin, 75 mg extended-release caps.

79-175

3/6/2009

Sun

Leuprolide acetate, 1 mg/0.2 mL inj.

78-885

3/9/2009

Generamedix

Pamidronate disodium, 30 mg/vial and 90 mg/vial inj.

78-300

3/10/2009

Akorn

Apraclonidine HCl, EQ 0.5% base ophthalmic solution/drops

77-764

3/12/2009

Sun

Promethazine HCl, 6.25 mg/5 mL syrup

40-891

3/13/2009

Apotex

Levetiracetam, 250 mg, 500 mg, 750 mg and 1 g tabs.

78-869

3/13/2009

Dr. Reddy's

Omeprazole, 10 mg and 20 mg delayed-release pellets caps.

78-693

3/16/2009

Barr

Minocycline HCl, EQ 45 mg base, EQ 90 mg base and EQ 135 mg base extended-release tabs.

65-485

3/17/2009

Kudco

Pantoprazole sodium, EQ 20 mg base and EQ 40 mg base delayed-release tabs.

78-281

3/17/2009

Mylan

Divalproex sodium, EQ 125 mg, EQ 250 mg and 500 mg valproic acid delayed-release tabs.

90-062

3/17/2009

Cephazone

Cefazolin sodium, EQ 500 mg base/vial and EQ 1 g base/vial inj.

65-280

3/18/2009

Cephazone

Cefazolin sodium, EQ 10 mg base/vial inj.

65-295

3/18/2009

Cephazone

Cefazolin sodium, EQ 20 mg base/vial inj.

65-296

3/18/2009

Aurobindo

Fluoxetine HCl, EQ 20 mg base/5 mL oral solution

79-209

3/19/2009

Alembic

Fluoxetine HCl, 10 mg, 20 mg and 40 mg caps.

90-223

3/19/2009

Cipla

Levetiracetam, 250 mg, 500 mg and 750 mg tabs.

77-319

3/20/2009

Cipla

Stavudine, 1 mg/mL oral solution

78-030

3/20/2009

Dey

Levalbuterol HCl, EQ 0.25% base inhalation solution

78-309

3/20/2009

Coastal Pharms

Liothyronine sodium, EQ 0.005 mg base, EQ 0.025 mg base and EQ 0.05 mg base tabs.

90-097

3/20/2009

Hikma Farmaceutica

Flumazenil, 0.5 mg/5 mL (0.1 mg/mL) and 1 mg/10 mL (0.1 mg/mL) inj.

78-527

3/23/2009

Perrigo

Sulfacetamide sodium, 10% topical lotion

78-649

3/23/2009

Cadista Pharms

Risperidone, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg tabs.

78-828

3/23/2009

Sagent Strides

Azithromycin, EQ 500 mg base/vial inj.

65-506

3/24/2009

Watson

Bupropion HCl, 150 mg extended-release tabs.

79-094

3/24/2009

Watson

Bupropion HCl, 100 mg, 150 mg and 200 mg extended-release tabs.

79-095

3/24/2009

Roxane

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

76-306

3/27/2009

Par

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

76-311

3/27/2009

Mylan

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

76-314

3/27/2009

Barr

Topiramate, 25 mg, 100 mg and 200 mg tabs.

76-315

3/27/2009

Teva

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

76-317

3/27/2009

Ranbaxy

Topiramate, 25 mg, 100 mg and 200 mg tabs.

76-327

3/27/2009

Cipla

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

76-343

3/27/2009

Glenmark

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

77-627

3/27/2009

Cobalt

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

77-643

3/27/2009

Apotex

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

77-733

3/27/2009

Zydus

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

78-235

3/27/2009

Aurobindo

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

78-462

3/27/2009

Torrent

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

79-153

3/27/2009

Unichem

Topiramate, 25 mg, 50 mg and 100 mg tabs.

90-162

3/27/2009

Sun

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

90-278

3/27/2009

KVK

Sodium polystyrene sulfonate, 454 mg/bottle oral rectal powder

40-905

3/30/2009

Pliva Hrvatska Doo

Topiramate, 25 mg, 50 mg, 100 mg and 200 mg tabs.

77-905

3/30/2009

Apotex

Budesonide, 0.25 mg/2mL inhalation suspension

78-202

3/30/2009

Tentative Approvals

Sandoz

Rosiglitazone maleate, 2 mg, 4 mg and 8 mg tabs.

78-674

3/9/2009

Alcon

Ketorolac tromethamine, 0.5% ophthalmic solution

76-583

3/10/2009

Matrix

Lopinavir/ritonavir, 200 mg; 50 mg tabs.

79-074

3/10/2009

Aurobindo

Lopinavir/ritonavir, 100 mg; 25 mg and 200 mg; 50 mg tabs.

90-471

3/10/2009

Teva

Divalproex sodium, 500 mg extended-release tabs.

78-700

3/16/2009

Alkem

Lamivudine, 150 mg tabs.

90-433

3/16/2009

Pharmacare

Stavudine/lamivudine, 30 mg; 150 mg and 40 mg; 150 mg tabs.

22-347

3/18/2009

Dr. Reddy's

Risperidone, 1 mg/mL oral solution

78-909

3/20/2009

Apotex

Azelastine HCl, 0.05% ophthalmic solution

78-621

3/23/2009

Matrix

Emtricitabine/tenofovir disoproxil fumarate, 200 mg/300 mg tabs.

90-049

3/30/2009

Aurobindo

Emtricitabine/tenofovir disoproxil fumarate, 200 mg/300 mg tabs.

90-513

3/30/2009

Matrix

Abacavir sulfate/lamivudine, 600 mg/300 mg tabs.

90-519

3/30/2009

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel